C9469 HCPCS Level II code: Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg
CMS terminated C9469: its last date of service was Jun 30, 2018. It stays here for looking up older claims; newer services need a current code.
Official description
C9469Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg
Short description: Inj triamcinolone acetonide
HCPCS · United States
Medicare details
The indicators CMS publishes with C9469 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Statute
- Type of service
- Other medical items or services; Ambulatory surgical center (facility usage for surgical services)
- BETOS category
- Other drugs
- Coverage statute
- 1833(t)
- Cross-reference
- See Q9993
- Added
- Apr 1, 2018
- Terminated after
- Jun 30, 2018
Where C9469 sits
- 1C codesOutpatient prospective payment system
- 2Terminated C9469Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code C9469 still valid?
No. CMS terminated C9469; its last date of service was Jun 30, 2018. It is listed for looking up services from before then. Use a current code for newer services.
Does Medicare cover C9469?
CMS lists C9469’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Statute”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside C9469
All C codesC9463Injection, aprepitant, 1 mgC9464Injection, rolapitant, 0.5 mgC9465Hyaluronan or derivative, durolane, for intra-articular injection, per doseC9466Injection, benralizumab, 1 mgC9467Injection, rituximab and hyaluronidase, 10 mgC9468Injection, factor ix (antihemophilic factor, recombinant), glycopegylated, rebinyn, 1 i.u.C9470Injection, aripiprazole lauroxil, 1 mgC9471Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mgC9472Injection, talimogene laherparepvec, 1 million plaque forming units (pfu)C9473Injection, mepolizumab, 1 mgC9474Injection, irinotecan liposome, 1 mgC9475Injection, necitumumab, 1 mg